Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.60
Bid: 77.60
Ask: 78.00
Change: -0.30 (-0.39%)
Spread: 0.40 (0.515%)
Open: 79.80
High: 79.80
Low: 77.60
Prev. Close: 77.90
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GCP Applied Technologies Receives European Patent on Sustainable Cement Grinding Methods

18 Oct 2018 11:00



GCP Applied Technologies Receives European Patent on Sustainable Cement Grinding Methods

Bio-derived Solutions Enhance Efficiency of Cement Grinding and Reduce CO2 Emissions

CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- GCP Applied Technologies Inc. (NYSE:GCP), a leading global provider of construction products technologies, is proud to announce the issuance of a patent for increasing the efficiency of cement grinding by using sustainable raw materials. The novel grinding aids and quality improvers allow the use of bio-derived glycerol and reduce the use and the impact of oil-derived chemicals.

This development continues GCP Applied Technologies’ commitment to offer cement producers a complete portfolio of products and services, enabling them to lead in cement quality, cost efficiency and sustainability. The new OPTEVA™ and TAVERO™ cement additives enable cement producers to reduce the energy consumption and the CO2 emissions associated with cement production, with a reduced use, or no use at all, of oil-derived chemicals.

“GCP Applied Technologies is focused on meeting the demands of modern cement plants,” said Dave Myers, vice president R&D and technical support. “We are committed to continuing research and development to improve cement additive products with innovative materials and services. GCP offers cement producers a complete portfolio of solutions that yield more sustainable cement production with enhanced quality and improved cost efficiency.”

European Patent No. EP 1 728 771 B1 has been granted and registered into seventeen European countries. The patent addresses methods for increasing the efficiency of cement and mineral grinding by using sustainable raw materials.

The patent relates to methods for improving the efficiency of grinding materials such as clinker and limestone, using glycerol derived from biofuel production, in combination with various grinding additives. GCP products can help shrink the carbon footprint of cement and concrete. Grinding aids and quality improvers make cement manufacturing more efficient, while concrete admixtures can reduce the amount of cement needed to achieve a given strength specification.

The company continues to expand its comprehensive portfolio of additives for cement production with high-performing quality improvers under the OPTEVA™ brand and innovative grinding aids under the TAVERO™ brand. 

Media RelationsPaul KeeffeT +1 617.498.4461mediainfo@gcpat.comInvestor RelationsJoseph DeCristofaroT +1 617.498.2616investors@gcpat.com

About GCP Applied Technologies

GCP is a leading global provider of construction products technologies that include additives for cement and concrete, the VERIFI® in-transit concrete management system, high-performance waterproofing products, and specialty systems. GCP products have been used to build some of the world’s most renowned structures. More information is available at www.gcpat.com.

This announcement contains “forward-looking statements,” that is, information related to future, not past, events. Such statements generally include the words “believes,” “plans,” “intends,” “targets,” “will,” “expects,” “suggests,” “anticipates,” “outlook,” “continues,” or similar expressions. Forward-looking statements include, without limitation, statements about expected financial positions; results of operations; cash flows; financing plans; business strategy; operating plans; capital and other expenditures; competitive positions; growth opportunities for existing products; benefits from new technology and cost reduction initiatives, plans and objectives; and markets for securities. Like other businesses, GCP is subject to risks and uncertainties that could cause its actual results to differ materially from its projections or that could cause other forward-looking statements to prove incorrect. Factors that could cause actual results to materially differ from those contained in the forward-looking statements, or that could cause other forward-looking statements to prove incorrect, include, without limitation, risks related to: the cyclical and seasonal nature of the industries that GCP serves; foreign operations, especially in emerging regions; changes in currency exchange rates; the cost and availability of raw materials and energy; the effectiveness of GCP’s research and development, new product introductions and growth investments; acquisitions and divestitures of assets and gains and losses from dispositions; developments affecting GCP’s outstanding liquidity and indebtedness, including debt covenants and interest rate exposure; developments affecting GCP’s funded and unfunded pension obligations; warranty and product liability claims; legal proceedings; the inability to establish or maintain certain business relationships and relationships with customers and suppliers or the inability to retain key personnel; and the handling of hazardous materials and the costs of compliance with environmental regulation. These and other factors are identified and described in more detail in GCP's Annual Report on Form 10-K, which has been filed with the U.S. Securities and Exchange Commission and is available online at www.sec.gov. Readers are cautioned not to place undue reliance on GCP’s projections and forward-looking statements, which speak only as the date thereof. GCP undertakes no obligation to publicly release any revision to the projections and forward-looking statements contained in this announcement, or to update them to reflect events or circumstances occurring after the date of this announcement.


Date   Source Headline
28th Apr 20236:11 pmRNSTotal Voting Rights
28th Apr 20235:00 pmRNSTransaction in Own Shares
28th Apr 20234:01 pmRNSChange of Registered Office
27th Apr 20237:00 amRNSNet Asset Value(s)
27th Apr 20237:00 amRNSDividend Declaration
19th Apr 20235:27 pmRNSTransaction in Own Shares
18th Apr 20235:49 pmRNSTransaction in Own Shares
5th Apr 20235:31 pmRNSTransaction in Own Shares
31st Mar 20235:18 pmRNSTotal Voting Rights
30th Mar 20237:00 amRNSDirector Declaration
29th Mar 20235:24 pmRNSTransaction in Own Shares
28th Mar 20234:53 pmRNSTransaction in Own Shares
27th Mar 20234:34 pmRNSTransaction in Own Shares
15th Mar 20235:15 pmRNSTransaction in Own Shares
14th Mar 20235:22 pmRNSTransaction in Own Shares
14th Mar 20237:00 amRNSShare Buyback Programme Initiated
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding
20th Feb 202312:27 pmRNSHolding(s) in Company
15th Feb 202311:42 amRNSResult of AGM
13th Feb 20233:25 pmRNSHolding(s) in Company
7th Feb 20234:52 pmRNSUpdate research from QuotedData
2nd Feb 202310:34 amRNSInvestor Report at 31 December 2022
31st Jan 20233:52 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSNet Asset Value(s)
27th Jan 20237:00 amRNSDividend Declaration
12th Jan 20239:55 amRNSNotice of net asset value announcements
11th Jan 20239:15 amRNSDirector Declaration
9th Jan 20239:15 amRNSNotice of AGM
15th Dec 20227:00 amRNSAnnual report and financial statements
28th Oct 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSInvestor Report at 30 September 2022
26th Oct 20227:00 amRNSDividend Declaration
20th Oct 20227:00 amRNSNet Asset Value(s)
30th Sep 202211:13 amRNSResult of EGM
30th Sep 20227:00 amRNSTotal Voting Rights
13th Sep 20225:21 pmRNSNotice of EGM
6th Sep 20229:18 amRNSAdditional Listing and Total Voting Rights
25th Aug 20229:30 amRNSAdditional Listing
11th Aug 20227:00 amRNSScrip Share Reference Price
29th Jul 20227:00 amRNSInvestor Report at 30 June 2022
27th Jul 202212:37 pmRNSResearch from QuotedData
26th Jul 202210:59 amRNSDividend Declaration & Scrip Dividend Alternative
14th Jul 20227:00 amRNSNet Asset Value(s)
30th Jun 20227:00 amRNSTotal Voting Rights
21st Jun 20227:05 amRNSDirectorate Change
21st Jun 20227:00 amRNSHalf-yearly report and financial statements 2022
7th Jun 20229:43 amRNSAdditional Listing and Total Voting Rights
26th May 20229:17 amRNSAdditional Listing
20th May 20223:56 pmRNSHolding(s) in Company
12th May 20227:00 amRNSScrip Share Reference Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.